“Network pharmacology and molecular docking identify eugenol as a lead compound targeting visceral leishmaniasis pathways with nanotechnology-driven drug design and nanoscale interaction analysis”, ETN, vol. 10, no. 3, pp. 1449–1468, Jul. 2026, doi: 10.56053/10.3.1449.